NCT03073876View on ClinicalTrials.gov

Detecting an Early Response to Donepezil With Measures of Visual Attention

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 1, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

January 13, 2021

Conditions
Alzheimer Disease
Interventions
DRUG

Donepezil Hydrochloride

5mg of Donepezil Hydrochloride by mouth

DRUG

Placebo

prepared placebo looking exactly the same as drug. Participants took placebo by mouth for approximately 6 weeks, and after unblinding, they took donepezil hydrochloride for 6 months.

Trial Locations (1)

11501

Winthrop-University Hospital, Mineola

All Listed Sponsors
collaborator

Queens College, The City University of New York

OTHER

lead

NYU Langone Health

OTHER

NCT03073876 - Detecting an Early Response to Donepezil With Measures of Visual Attention | Biotech Hunter | Biotech Hunter